Fingerprint
Dive into the research topics of 'Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer
R. S. Finn, D. H. Ahn, M. M. Javle, B. R. Tan, C. D. Weekes, J. C. Bendell, A. Patnaik, G. N. Khan, D. Laheru, R. Chavira, J. Christy-Bittel, E. Barrett, M. B. Sawyer, Tanios S. Bekaii-Saab
Research output: Contribution to journal › Article › peer-review
24
Scopus
citations